However, in tumor samples from late-stage ovarian cancer patients (III, Mets), SMARCE1 expression increased and was highest in tumors invading into regional lymph nodes and distant organs (Fig. 2 B, Right and SI Appendix, Fig. S1). The gene discussed is SMARCE1; the disease is ovarian cancer.